Quality of life, health outcomes and cost-effectiveness
Please note: this is a legacy publication from CPEC (formely PSSRU at LSE).European Neuropsychopharmacology supplement
Abstract
Whilst most attention in research and in treatment rightly focuses on the symptoms of schizophrenia and on side-effects, patients and families are also concerned about social interaction, employment, family burden and the subjective experiences of what